Health
At AGBT, Complete Genomics showcases expanded sequencing applications, talks from customers and collaborators on research powered by the DNBSEQ-T7 Sequencer
The genomic sequencing solutions provider also introduces Q40 sequencing
quality, announces new DNBSEQ products
SAN JOSE, Calif., Feb. 6, 2024 /PRNewswire/ -- Complete Genomics,
2024-02-06 22:00
1475
BrainGear Develops SleePYA, the Digital Healthcare for Brain Rehabilitation and Sleep Aid
SEOUL, South Korea, Feb. 5, 2024 /PRNewswire/ -- As startup engaging in digital
healthcare business, especially brain rehabilitation and sleep aid, BrainGear
has developed SleePYA with infrared light to stimulate the brain to induce
quality of sleep.
2024-02-05 22:00
1502
Genesis MedTech Completes Enrollment in its United States Early Feasibility Study Utilizing the J-Valve™ Transfemoral System for Patients with Severe Aortic Regurgitation
JC Medical reports milestone accomplishment with its TAVR device BURLINGAME, Calif., Feb. 5, 2024 /PRNewswire/ -- Genesis MedTech, a leading medical device company, today announced the completion of enrollment in its United States Early Feasibility Study (EFS) using its dedicated transcatheter ...
2024-02-05 22:00
1417
Deep Sleep in 10 minutes: MOZA Launches the Sleepris Eye Massager to Induce Better Sleep and Reduce Stress
IRVINE, Calif. , Feb. 5, 2024 /PRNewswire/ -- MOZA Technology ("MOZA'' or "the Company"), a pioneer in mindfulness and relaxation technology, has launched Sleepris, the first smart eye massager designed for comfortable all-night wear. Designed to alleviate insomnia, prevent sleep loss and reduce ...
2024-02-05 22:00
1847
Rokit Healthcare Scores High Marks in KOSDAQ Tech Listing Evaluation
SEOUL, South Korea, Feb. 5, 2024 /PRNewswire/ -- Rokit Healthcare, a trailblazer in AI-driven medical bioprinting technology, proudly announces its achievement of an AA rating in the KOSDAQ (Korea Securities Dealers Automated Quotations) technology listing evaluation. Garnering A grades from both...
2024-02-05 22:00
2031
NouvNeu001 Achieves Milestone with Successful Dosing of First Patient, Signaling Smooth Progress in iRegene Therapeutics' Multicenter Clinical Trial for Innovative Novel Parkinson's Disease Therapy
WUHAN, China, Feb. 5, 2024 /PRNewswire/ -- iRegene Therapeutics Co., Ltd (iRegene) recently announced that NouvNeu001, the company's first innovative product, has completed the dosing for its first patient at Beijing Hospital, and the patient has also successfully concluded the observation per...
2024-02-05 21:00
1728
Technoderma Medicines Phase 2 Clinical Trial of TDM-105795 Demonstrates Hair Growth in Androgenetic Alopecia
CHENGDU, China, Feb. 5, 2024 /PRNewswire/ -- Technoderma Medicines, Inc. ("the Company"), a clinical stage biopharmaceutical company, is pleased to report that the Company has completed its Phase 2a clinical trial (NCT05802173) of TDM-105795 topical solution for Androgenetic Alopecia (AGA). This ...
2024-02-05 21:00
1496
Wingderm® "Dual Innovation, Infinite Possibilities" Global Distributor conference was successfully held at IMCAS
BEIJING, Feb. 5, 2024 /PRNewswire/ -- IMCAS World Congress 2024 was held in Paris, France from February 1st to 3rd. On the first day, Wingderm® successfully held the "Dual Innovation, Infinite Possibilities" new device release conference for its signed distributors worldwide, along with Renuva® ...
2024-02-05 16:50
1353
Acepodia Announces FDA Clearance of Investigational New Drug Application for ACE2016, a First-in-Class Allogeneic Anti-EGFR Cell Therapy
* ACE2016 Is an Allogeneic Gamma Delta 2 (γδ2) T Cell Therapy Targeting the Epidermal Growth Factor Receptor (EGFR) in Patients With Solid Tumors. * Phase 1 Clinical Study Expected to Begin in H2 2024. ALAMEDA, Calif. and TAIPEI, Feb. 4, 2024 /PRNewswire/ -- Acepodia (6976:TT), a clinical stag...
2024-02-05 08:00
1466
Blossoming Flowers at the Top of the Biopharmaceutical Tree -- Reflections on the Flourishing of Sanyou's 4C Business
SHANGHAI, Feb. 2, 2024 /PRNewswire/ -- In 1996, MDS Pharma Service invested in and established the first true Contract Research Organization (CRO) inChina, dedicated to clinical trial business for new drugs. This marked the official launch of the CRO industry inChina. The concept of CRO originat...
2024-02-03 08:00
2430
Inmagene Exercises Option to Obtain Exclusive Worldwide License for IMG-007 and IMG-004 from HUTCHMED
* Inmagene exercised its option under the previously announced collaboration agreement to obtain an exclusive, royalty-bearing license for IMG-007, an anti-OX40 monoclonal antibody (mAb) and IMG-004, a Bruton Tyrosine Kinase (BTK) inhibitor * Inmagene retains rights to develop and commerciali...
2024-02-02 22:00
2210
Wingderm® Launches Lasermach2, Revolutionizing Hair Removal Solution, at IMCAS World Congress 2024 in Paris
BEIJING, Feb. 2, 2024 /PRNewswire/ -- In the morning of February 1st, Wingderm® announced the launch of Lasermach2 at IMCAS World Congress 2024 in Paris, which represents another revolutionizing breakthrough by Wingderm® in medical aesthetics industry. Wingderm® founder and CEO, Will Wang, as th...
2024-02-02 17:00
1580
2024 Global Appeal Calls for Well-Informed Public to 'Break Chains of Discrimination' against Leprosy
TOKYO, Feb. 1, 2024 /PRNewswire/ -- Sasakawa Leprosy (Hansen's Disease) Initiative has partnered with the World Health Organization to co-host the launch of the 2024 Global Appeal to end stigma and discrimination against persons affected by leprosy at WHO headquarters inGeneva on January 31, 2024...
2024-02-01 14:00
1611
Euromonitor International names USANA Malaysia and Singapore Top #1 Brand for Probiotic Supplements When Combined
SALT LAKE CITY, Feb. 1, 2024 /PRNewswire/ -- USANA Malaysia and Singapore were
recently awarded the title of Top #1 Brand for Probiotic Supplements in Malaysia
andSingapore when combined by Euromonitor International. This exclusive award
is based on Euromonitor's market research of USANA.
2024-02-01 12:28
1759
Promising Clinical Results on the World's First Use of BCMA CAR-T to Treat Immune Mediated Necrotizing Myopathy (IMNM) Published on the Proceedings of the National Academy of Sciences (PNAS)
SHANGHAI, NANJING, China and SAN JOSE, Calif., Jan. 31, 2024 /PRNewswire/ -- On Jan. 30, 2024, PNAS published the research paper titled "Single-cell analysis of refractory anti-SRP necrotizing myopathy treated with anti-BCMA CAR T-cell therapy." The paper analyzed results using the fully human B ...
2024-02-01 11:07
1915
Anbogen Secures 12.5 Million in Series A Funding, Advancing Precision Oncology Drug Development
TAIPEI, Jan. 31, 2024 /PRNewswire/ -- Anbogen Therapeutics, a clinical-stage biotechnology company specializing in groundbreaking cancer drug development, today announced the successful completion of its Series A funding round. The lead investor is China Development Industrial Bank (CDIB), with s...
2024-02-01 00:00
1649
Amcor announces expansion of thermoforming production capacity to support healthcare customer growth in North America
DEERFIELD, Ill., Jan. 31, 2024 /PRNewswire/ -- Amcor (NYSE: AMCR, ASX:AMC), a
global leader in developing and producing responsible packaging solutions,
today announced a significant expansion of its North American thermoforming
capabilities for the healthcare market.
2024-01-31 23:30
3339
A Korean UV Sensor Manufacturer, Genicom Introduces Breakthrough Far UV & VUV Optical Sensor for Safe and Efficient Pathogen Control
SEOUL, South Korea, Jan. 31, 2024 /PRNewswire/ -- The COVID-19 pandemic is an ongoing challenge of emerging and re-emerging infectious pathogens. Ultraviolet (UV) has high energy in the wavelength range of 100 ~ 400nm and is used for sterilization, air purification, medical treatment, etc. by bre...
2024-01-31 22:00
1541
Crystal Pharmatech's CDMO Business Unit - Crystal Formulations Services Successfully Passed EU QP Audit
SUZHOU, China, Jan. 31, 2024 /PRNewswire/ -- Recently, Crystal Formulations Services (CFS), the CDMO Business Unit of Crystal Pharmatech has achieved a significant milestone by successfully passing the on-site audit conducted by the European Qualified Person (QP), evaluating its GMP quality syste...
2024-01-31 21:00
1178
WuXi Biologics Successfully Completes First 1,6000L Manufacturing Run in Ireland
- First manufacturing run successful for MFG7 facility at the Ireland site - Largest manufacturing scale to date achieved by combining four 4,000-liter single-use bioreactors DUNDALK, Ireland, Jan. 31, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Researc...
2024-01-31 17:31
2480
Week's Top Stories
Most Reposted
Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
[Picked up by 319 media titles]
2024-11-07 09:00
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 313 media titles]
2024-11-12 09:00
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 290 media titles]
2024-11-13 09:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 289 media titles]
2024-11-12 11:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
Most Read
Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
2024-11-07 09:00
10141
XtalPi and Sinar Mas Multiartha Launch Strategic Partnership to Revolutionize AI Across Asia-Pacific
2024-11-07 11:34
7500
XTEP's First Mono Store in Malaysia Comes to Puchong
2024-11-07 10:08
6214
